Natera Inc’s filing revealed that its PRESIDENT, CLINICALDIAGNOSTICS Moshkevich Solomon unloaded Company’s shares for reported $0.68 million on Jan 02 ’26. In the deal valued at $228.95 per share,2,951 shares were sold. As a result of this transaction, Moshkevich Solomon now holds 123,499 shares worth roughly $29.08 million.
Then, Chapman Steven Leonard sold 3,848 shares, generating $881,482 in total proceeds. Upon selling the shares at $229.08, the CEO AND PRESIDENT now owns 136,568 shares.
Before that, SOLOMON MOSHKEVICH bought 2,951 shares. Natera Inc shares valued at $675,621 were divested by the Officer at a price of $228.95 per share.
Citigroup initiated its Natera Inc [NTRA] rating to a Buy in a research note published on January 07, 2026; the price target was $300. BNP Paribas Exane also remained covering NTRA and has increased its forecast on October 27, 2025 with a “Neutral” recommendation from previously “an Underperform” rating.
Price Performance Review of NTRA
On Monday, Natera Inc [NASDAQ:NTRA] saw its stock jump 0.49% to $235.45. Over the last five days, the stock has lost -0.83%. Natera Inc shares have risen nearly 33.32% since the year began. Nevertheless, the stocks have risen 2.78% over the past one year.
How much short interest is there in Natera Inc?
A steep rise in short interest was recorded in Natera Inc stocks on 2025-12-31, growing by 0.73 million shares to a total of 4.75 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 4.02 million shares. There was a rise of 15.33%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 13, 2025 when RBC Capital Mkts began covering the stock and recommended ‘”an Outperform”‘ rating along with a $251 price target.
